This inventor holds 1 USPTO granted patent. Top assignee: University of Delaware. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Innovations of Maksim Royzen in Bio-Orthogonal Chemistry
Introduction
Maksim Royzen is an accomplished inventor based in Philadelphia, PA. He has made significant contributions to the field of bio-orthogonal chemistry, particularly through his innovative patent. His work focuses on developing coupling reagents that are applicable in various biological media.
Latest Patents
Maksim Royzen holds a patent for "Tetrazine-based bio-orthogonal coupling reagents and methods." This patent describes coupling reactions that are suitable for use in both organic and aqueous media. The process involves contacting a 1,2,4,5-tetrazine with a dienophile, which may be covalently bonded to a protein. The coupling reaction can be performed in biological media, including those containing cells or cell lysates. The reactions can occur in the presence of primary amines, thiols, acetylenes, azides, phosphines, and products of Staudinger and/or Sharpless-Huisgen reactions. Notably, novel 3-substituted cyclopropene compounds and trans-cyclooctenes serve as exemplary dienophiles for these reactions. Maksim Royzen has 1 patent to his name.
Career Highlights
Maksim Royzen is affiliated with the University of Delaware, where he continues to advance his research in bio-orthogonal chemistry. His academic background and ongoing research contribute to the innovative landscape of this scientific field.
Collaborations
Maksim collaborates with notable colleagues, including Joseph M. Fox and Melissa Blackman. Their combined expertise enhances the research and development of bio-orthogonal methods.
Conclusion
Maksim Royzen's contributions to bio-orthogonal chemistry through his innovative patent demonstrate his commitment to advancing scientific knowledge. His work has the potential to impact various applications in biological research and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
